Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from INCY

4 A-Rated Biotech Stocks Sparking Investor Interest

The biotech industry is rapidly evolving thanks to the surging biopharma M&A activity and incorporation of new technological trends like AI and gene editing. Given this backdrop, quality biotech stocks Gilead Sciences (GILD), Equillium (EQ), Incyte Corporation (INCY), and Jazz Pharmaceuticals plc (JAZZ), rated A (Strong Buy) overall in our…

StockNews.com

Top 3 Biotech Stocks to Consider for March Profits

The biotech sector’s growth prospects look promising thanks to the growing use of cutting-edge technologies in healthcare and the rising popularity of personalized medicines. Therefore, it could be wise to buy fundamentally strong biotech stocks Shionogi (SGIOY), Alkermes (ALKS), and Incyte (INCY) for March profits. Read more.

StockNews.com

Elite 4 Biotech Stocks to Buy Now for Explosive Returns

With a wide range of applications across sectors, including health, agriculture, and industrial processing, rapid technological adoption, and government support, the biotech industry’s prospects appear promising. Thus, investors could consider buying biotech stocks Corcept Therapeutics (CORT), Jazz Pharmaceuticals (JAZZ), Incyte (INCY), and Exelixis (EXEL) for substantial gains. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stock Sensations to Snatch up This Week

The future of the biotech industry appears promising, fueled by technology-driven advancements, increasing merger and acquisition maneuvers, and developing product pipelines. Given this backdrop, quality biotech stocks BioNTech SE (BNTX), Entrada Therapeutics (TRDA), and Incyte Corporation (INCY) could be wise to snatch up this week. Read on….

StockNews.com

2 Best Growth Stocks to Buy with $1,000 Right Now

Growth stocks are getting ready for a comeback year in 2024, and these two under-the-radar stocks have solid financials and significant upside potential.

Barchart

3 Food Maker Stock Buys for Year-End Success

The global food service industry is thriving, fueled by diverse culinary preferences and technological integration. Hence, fundamentally strong food maker stocks Danone (DANOY), Ingredion Incorporated (INGR), and Tate & Lyle (TATYY) might be solid investments for year-end gains. Read more….

StockNews.com

Top 4 Biotech Stock Buys for 2024 Gains

The biotech industry's dynamic growth, spurred by government backing and technological advances, addresses rising disease challenges and propels advancements in healthcare. Hence, fundamentally strong biotech stocks Gilead Sciences (GILD), Incyte Corporation (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be solid investments for upcoming year gains. Read more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Are These the Top 3 Biotech Stocks Set for Year-End Profits?

As the biotech industry experiences robust growth, driven by innovation, government initiatives, and global market expansion, let us delve into fundamentally solid biotech stocks Gilead Sciences (GILD), Exelixis (EXEL), and Incyte Corp (INCY) to evaluate their year-end profitability potential. Read more to find out….

StockNews.com

3 Biotech Stocks Bursting With Investment Potential

The biotech industry is well-positioned for robust growth thanks to the increasing demand for effective treatments for chronic diseases and the need to serve an aging population. To capitalize on the favorable industry trends, investing in quality biotech stocks Organogenesis Holdings (ORGO), Genmab A/S (GMAB), and Incyte (INCY) could be…

StockNews.com

3 Revolutionary Biotech Stocks Worth Investing In

The biotech industry's upward momentum is underpinned by the growth of personalized medicine, orphan drugs, innovative biotech tools, and robust government backing. Hence, revolutionary biotech stocks Equillium (EQ), Protalix BioTherapeutics (PLX), and Incyte Corporation (INCY) could make ideal additions to your portfolio at present. Read more….

StockNews.com

Exploring the Upside Potential of 3 Biotech Stocks

Given the breakthrough developments, government support, and rising need to treat chronic diseases, the biotech industry is well-positioned to grow steadily. So, it could be wise to invest in quality biotech stocks Alkermes (ALKS), Amgen (AMGN) and Incyte (INCY). Read on….

StockNews.com

Investors Keeping a Close Eye on These 3 Biotech Stocks

Growing adoption of AI technologies by biopharmaceutical companies and growing foothold of personalized medicine are expected to drive growth in the biotech market. Therefore, it could be wise to buy fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Corcept Therapeutics (CORT), and Incyte (INCY). Read more.

StockNews.com

3 Biotech Stocks to Buy under $20

The growing adoption of advanced technologies by biopharmaceutical companies and the growing demand for personalized medicines are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks MacroGenics (MGNX), Acorda Therapeutics (ACOR), and Shionogi & Co. (SGIOY), which are currently trading under $20.…

StockNews.com

Which of These 3 Biotech Stocks Are a Buy, Sell, or Hold?

Advanced medical technologies and the pivotal role of technology in drug development are poised to drive significant growth in the biotech industry. Against this backdrop, should you buy, sell or hold biotech stocks Moderna (MRNA), MacroGenics (MGNX), and Amicus Therapeutics (FOLD)? Let’s find out….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Best Biotech Stocks for Health and Wealth

With medical innovations and technological breakthroughs rapidly transforming the healthcare landscape, biotech stocks have garnered unprecedented attention in the investment community. Thus, fundamentally robust stocks like Incyte Corp. (INCY), Vertex Pharmaceuticals (VRTX), and Amgen (AMGN) could contribute to the health and wealth of your portfolios. Read more….

StockNews.com

Invest in These 3 High-Growth Biotech Stocks

Technological improvements, government, and private investment, and favorable regulatory policies are propelling the biotech industry’s growth and offering breakthrough cures and products. With the industry expected to thrive, fundamentally strong biotech stocks Genmab (GMAB), Incyte (INCY), and LAVA Therapeutics (LVTX) look poised for solid growth. Hence, these stocks could be…

StockNews.com

Are These 3 Biotech Stocks Good Buys?

Given that the biotech sector is rapidly expanding with robust demand, technology advancements, and government initiatives, fundamentally strong biotech stocks Incyte (INCY), Corcept Therapeutics (CORT), and Entrada Therapeutics (TRDA) look poised to generate significant returns. Hence, these stocks could be solid additions to your portfolio. Read on.

StockNews.com

3 Biotech Stocks Poised to Skyrocket

On the backs of successful trials and breakthrough therapies, the biotech market is poised to thrive. Therefore, scooping up the shares of fundamentally sound biotech stocks such as BioMarin Pharmaceutical (BMRN), Incyte Corp. (INCY), and Innoviva (INVA) could be beneficial. Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

The 3 Best Biotech Stocks to Buy for Under $100

Despite macroeconomic uncertainties, the biotech industry is anticipated to thrive amid robust demand and lucrative government initiatives. Given the promising prospects of the industry, quality stocks Gilead Sciences (GILD), Incyte (INCY), and Taisho Pharmaceutical (TAIPY) might be wise additions to your portfolio. These stocks are currently trading under $100. Keep…

StockNews.com

3 Low-Volatility Stocks to Invest in Right Now

U.S. GDP declined for the second straight quarter from April to June, adding to the recession concerns. Moreover, considering the lingering macroeconomic headwinds, we think it could be wise to scoop up shares of low-volatility stocks Leidos (LDOS), Incyte (INCY), and The Coca-Cola Company (KO) now. Keep reading….

StockNews.com

3 Stocks the World's Greatest Investors Are Buying up Right Now

Skyrocketing inflation, the Fed’s aggressive interest rate hikes, and growing recession fears have kept the stock market under tremendous pressure lately. Amid the market’s downtrend, the world’s renowned investors are scooping up quality stocks Occidental Petroleum (OXY), Amazon.com (AMZN), and Incyte (INCY). Continue reading….

Benzinga

Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?

Image sourced from Shutterstock

StockNews.com

3 Bargain Stocks Near 52-Week Lows to Buy and Forget

The lingering inflation and the Fed’s aggressive rate hikes are taking a toll on the market. However, we think it could be wise to buy and hold financially robust bargain stocks Meta Platforms (META), Micron Technology (MU), and Incyte (INCY), which are currently trading near 52-week lows. Keep reading….

Benzinga

CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Eli Lilly And Co (NYSE:LLY) and Incyte Corporation's (NASDAQ:INCY) Olumiant (baricitinib) for severe alopecia areata (AA). If approved, Olumiant would be the first centrally-authorized oral treatment and first JAK inhibitor for severe AA in the European Union. …

StockNews.com

3 Buy-Rated Biotechs to Buy in May

Despite logistical hurdles, the biotech industry is expected to expand solidly in the coming years on lucrative federal investments and strong demand. Therefore, we think it could be wise to bet on the stocks of quality biotech companies Biogen (BIIB), BioNTech (BNTX), and Incyte (INCY). These stocks are rated ‘Buy’…

1 2 3

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations